Cheplapharm Arzneimittel GmbH
(the “Issuer”)
Ziegelhof 24, 17489 Greifswald, Germany
Satisfaction Notice of Redemption of
U.S.$500,000,000 5.500% Senior Secured Notes due 2028 of the Issuer (the “Notes”)
Reg S: ISIN: USD1T29ZAB81 / Common Code: 224772238 / CUSIP: D1T29ZAB8
144A: ISIN: US16412EAA55 / Common Code: 222197848 / CUSIP: 16412EAA5
On January 28, 2026, the Issuer delivered a conditional notice of redemption (the “Notice of Conditional Full Redemption”) in full of its U.S.$500,000,000 5.500% Senior Secured Notes due 2028 (the “Notes”).
The Issuer confirms that the Financing Condition (as defined in the Notice of Conditional Full Redemption) has been satisfied on February 9, 2026. The redemption of the Notes will occur on February 10, 2026 (the “Redemption Date”). The total redemption amount for the Notes is U.S.$215,000,000. The redemption price of the Notes is 100.000% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest from (and including) January 15, 2026 (the last date upon which interest on the Notes was paid) to, but not including, the Redemption Date and Additional Amounts, if any (the “Redemption Price”), which comprises (i) the principal amount of the Notes to be redeemed of U.S.$215,000,000 and (ii) accrued but unpaid interest equal to U.S.$821,180.56.